Dr. Jon Heinrichs, Director, Microbial Vaccines, Merck Research Laboratories, to Deliver Featured Speech at 9th Annual Vaccines Discovery and Development: All Things Considered Conference (Nov. 7-8, 2011, in Boston, MA)
Dr. Heinrichs will discuss the development of vaccines for the prevention of Chlamydia trachomatis genital infections. Chlamydia trachomatis is a leading cause of both ocular disease (trachoma) and urogenital infections, and is the most commonly reported sexually transmitted disease in the United States. Although genital infection with chlamydia is frequently asymptomatic, failure to treat women can lead to serious health conditions including pelvic inflammatory disease and infertility. Merck, in collaboration with the University of Texas Health Sciences Center and the...
View full press release